...inspection-related conditions, according to the company.Atomwise, FutuRx launch A2iAI drug discovery company Atomwise Inc. and FutuRx...
...funding to develop small molecules for immuno-oncology. The deal represents Atomwise’s second partnership with a global incubator hub. FutuRx...

...is not an option because you can’t dose it high enough." Pi was incubated at FutuRx...
...a total of about $24 million to date, including a $2 million seed round from FutuRx...

...samples to correlate the target bacteria to the disease. Since its inception in OrbiMed Advisors’ FutuRx...

...samples to correlate the target bacteria to the disease. Since its inception in OrbiMed Advisors’ FutuRx...

...considering” umbrella agreements but declined to give details. Silverstein and Gordon pointed to the firm’s FutuRx...
...Johnson & Johnson Innovation LLC subsidiary of Johnson & Johnson -- as its closest comparator. FutuRx...
...financial support to companies and positions them for subsequent funding rounds. “A compelling feature of FutuRx...

...‘what about trying to take it out?’” said Solomon. Since its inception in OrbiMed Advisors’ FutuRx...

...research; fund buys institutions' co-investment rights in exchange for a cut of future fund profits FutuRx...
...Takeda Ventures $2.1M base budget per project, up to 85% from OCS, and payment-in-kind consideration FutuRx...

...of excess mitochondrial fission that could help prevent Huntington's disease. The company was incubated at FutuRx...
...BioCentury that Takeda sponsored Mochly-Rosen's work at Stanford and recommended the technology for development at FutuRx...

...incubator FutuRx Ltd. The fund expects to complete a second closing “in the near future.” FutuRx...

...can select the right time to enter into a strategic relationship." BiomX is housed in FutuRx...
...Innovations, Jan. 16, 2014) . J&J does not have preferential rights to BiomX or any FutuRx...